Measles vaccines and the potential for worldwide eradication of measlesMEISSNER, H. Cody; STREBEL, Peter M; ORENSTEIN, Walter A et al.Pediatrics (Evanston). 2004, Vol 114, Num 4, pp 1065-1069, issn 0031-4005, 5 p., 1Article

Economic analysis of the 1996-1997 mass measles immunization campaigns in South AfricaUZICANIN, Amra; FANGJUN ZHOU; EGGERS, Rudi et al.Vaccine. 2004, Vol 22, Num 25-26, pp 3419-3426, issn 0264-410X, 8 p.Article

Measles - The epidemiology of eliminationDURRHEIM, David N; CROWCROFT, Natasha S; STREBEL, Peter M et al.Vaccine. 2014, Vol 32, Num 51, pp 6880-6883, issn 0264-410X, 4 p.Article

Global Progress Toward Measles Eradication and Prevention of Rubella and Congenital Rubella SyndromeCOCHI, Stephen L; STREBEL, Peter; HOEKSTRA, Edward et al.The Journal of infectious diseases. 2011, Vol 204, issn 0022-1899, 575 p., SUP1Serial Issue

The Cost-Effectiveness of Supplementary Immunization Activities for Measles: A Stochastic Model for UgandaBISHAI, David; JOHNS, Benjamin; NAIR, Divya et al.The Journal of infectious diseases. 2011, Vol 204, issn 0022-1899, S107-S115, SUP1Article

Who Gets Measles in Europe?MUSCAT, Mark.The Journal of infectious diseases. 2011, Vol 204, issn 0022-1899, S353-S365, SUP1Article

Status of Rubella and Congenital Rubella Syndrome Surveillance, 2005-2009, the World Health Organization European RegionZIMMERMAN, Laura A; MUSCAT, Mark; JANKOVIC, Dragan et al.The Journal of infectious diseases. 2011, Vol 204, issn 0022-1899, S381-S388, SUP1Article

Progress Toward Measles Elimination in the People's Republic of China, 2000-2009CHAO MA; ZHIJIE AN; WEIZHONG YANG et al.The Journal of infectious diseases. 2011, Vol 204, issn 0022-1899, S447-S454, SUP1Article

Epidemiology of a Measles Epidemic in Vietnam 2008-2010SNIADACK, David H; MENDOZA-ALDANA, Jorge; DANG THI THANH HUYEN et al.The Journal of infectious diseases. 2011, Vol 204, issn 0022-1899, S476-S482, SUP1Article

Dried Blood Spots on Filter Paper as an Alternative Specimen for Measles Diagnostics: Detection of Measles Immunoglobulin M Antibody by a Commercial Enzyme ImmunoassayUZICANIN, Amra; LUBEGA, Irene; NANUYNJA, Miriam et al.The Journal of infectious diseases. 2011, Vol 204, issn 0022-1899, S564-S569, SUP1Article

Predictors of influenza vaccination in HIV-infected patients in the United States, 1990-2002. CommentaryHELFAND, Rita F; PERRY, Robert; STREBEL, Peter et al.The Journal of infectious diseases. 2007, Vol 196, Num 3, issn 0022-1899, 333-335, 339-346 [11 p.]Article

Experience in global measles control, 1990-2001HENAO-RESTREPO, Ana-Maria; STREBEL, Peter; HOEKSTRA, Edward John et al.The Journal of infectious diseases. 2003, Vol 187, pp S15-S21, issn 0022-1899, SUP1Article

Measles incidence before and after mass vaccination campaigns in Burkina FasoKAMBIRE, Chantal; KONDE, M. Kader; YAMEOGO, André et al.The Journal of infectious diseases. 2003, Vol 187, pp S80-S85, issn 0022-1899, SUP1Article

Interruption of Measles transmission in Brazil, 2000-2001PREVOTS, D. Rebecca; PARISE, M. Salet; SEGATTO, Teresa Cristina V et al.The Journal of infectious diseases. 2003, Vol 187, pp S111-S120, issn 0022-1899, SUP1Article

Measles and rubella in the World Health Organization European region: Diversity creates challengesSPIKA, John S; WASSILAK, Steven; PEBODY, Richard et al.The Journal of infectious diseases. 2003, Vol 187, pp S191-S197, issn 0022-1899, SUP1Article

Update on the global distribution of genotypes of wild type measles virusesROTA, Paul A; BELLINI, William J.The Journal of infectious diseases. 2003, Vol 187, pp S270-S276, issn 0022-1899, SUP1Article

Limited diversity of measles field isolates after a National Immunization day in Burkina Faso: Progress from endemic to epidemic transmission?MULDERS, Mick N; NEBIE, Yacouba K; FACK, Fred et al.The Journal of infectious diseases. 2003, Vol 187, pp S277-S282, issn 0022-1899, SUP1Article

Ensuring injection safety during measles immunization campaigns: More than auto-disable syringes and safety boxesHERSH, Bradley S; CARR, Richard M; FITZNER, Julia et al.The Journal of infectious diseases. 2003, Vol 187, pp S299-S306, issn 0022-1899, SUP1Article

Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance dataSIMONS, Emily; FERRARI, Matthew; FRICKS, John et al.Lancet (British edition). 2012, Vol 379, Num 9832, pp 2173-2178, issn 0140-6736, 6 p.Article

Persistence of Vaccine-Induced Measles Antibody Beyond Age 12 Months: A Comparison of Response to One and Two Doses of Edmonston- Zagreb Measles Vaccine Among HIV-Infected and Uninfected Children in MalawiFOWLKES, Ashley; WITTE, Desiree; CUTTS, Felicity et al.The Journal of infectious diseases. 2011, Vol 204, issn 0022-1899, S149-S157, SUP1Article

Measles Mortality Reduction and Pre- Elimination in the African Region, 2001-2009MASRESHA, Balcha G; FALL, Amadou; ESHETU, Messeret et al.The Journal of infectious diseases. 2011, Vol 204, issn 0022-1899, S198-S204, SUP1Article

Preplanned National Measles Vaccination Campaign at the Beginning of a Measles Outbreak-Sierra Leone, 2009-2010SUGERMAN, David E; FALL, Amadou; GUIGUI, Marie-Thérèse et al.The Journal of infectious diseases. 2011, Vol 204, issn 0022-1899, S260-S269, SUP1Article

What Will It Take to Achieve Measles Elimination in the World Health Organization European Region: Progress From 2003-2009 and Essential Accelerated ActionsMARTIN, Rebecca; WASSILAK, Steven; EMIROGLU, Nedret et al.The Journal of infectious diseases. 2011, Vol 204, issn 0022-1899, S325-S334, SUP1Article

Closer to the Goal: Efforts in Measles Elimination in Germany 2010SIEDLER, Anette; MANKERTZ, Annette; REITER, Sabine et al.The Journal of infectious diseases. 2011, Vol 204, issn 0022-1899, S373-S380, SUP1Article

Progress and Challenges for Measles Elimination by 2012 in the Western Pacific RegionSNIADACK, David H; MENDOZA-ALDANA, Jorge; JEE, Youngmee et al.The Journal of infectious diseases. 2011, Vol 204, issn 0022-1899, S439-S446, SUP1Article